Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TLACPH Consulting ApS
APS
Active
CVR 40250360
Hovmarksvej 73
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2019
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 36K
-54% vs 2024
EBITDA margin
100.0%
-43% vs 2024
Equity ratio
55.0%
Financial strength
Net profit 2025
DKK 34K
-36% vs 2024
EBITDA — year on year
DKK millions
0M
1M
1M
2M
3M
0M
2020
2M
+200%
2021
1M
-50%
2022
0M
-100%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 36K
-54%
EBITDA
DKK 36K
-43%
Net profit
DKK 34K
-36%
Total assets
DKK 276K
+12%
Equity
DKK 152K
-10%
Employees
—
—
Company information
Legal name
TLACPH Consulting ApS
CVR number
40250360
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
11. februar 2019
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør alene
Company purpose
Virksomhedens formål er at udvikle farmaceutiske præparater
Contact
Address
Hovmarksvej 73
Phone
+4525374486
Email
cphtla@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Gentofte
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
0M
2020
2M
2021
1M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
1M
1M
2M
2M
0M
2020
2M
2021
1M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
2025
Revenue
0
2.048
950
176
78
36
Staff expenses
-0
-0
-0
-0
-0
-0
EBITDA
0
2.048
950
176
63
36
Depreciation & amort.
-0
-0
-0
-0
-0
-0
EBIT
0
2.048
950
176
63
36
Net financials
0
0
193
114
5
8
Profit before tax
0
2.048
1.143
290
68
44
Tax
-0
451
253
64
15
10
Net profit
0
1.597
890
226
53
34
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
2025
Total assets
0
2.064
2.524
403
247
276
Equity
0
1.597
2.488
314
167
152
Long-term debt
0
0
0
0
0
0
Short-term debt
0
435
36
89
80
124
Total debt
0
435
36
89
80
124
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2020
2025
Equity ratio
55.0%
This company
38.2%
Market median
+44% vs market
2020
2025
Return on equity
22.5%
This company
18.4%
Market median
+22% vs market
2020
2025
Net profit margin
94.7%
This company
8.1%
Market median
+1069% vs market
2020
2025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
2020
2025
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
2020
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-05-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-02-11 – 2020-04-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
TL
Thomas Lars Andresen
Chief Executive Officer
Chief Executive Officer
2019
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
TLA-HOLDING 2010 ApS
Company
100.0%
100.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
TLA-HOLDING 2010 ApS
TLACPH Consulting ApS
(this company)
Board network connections
Board members of TLACPH Consulting ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Thomas Lars Andresen
Chief Executive Officer
0 companies